Patient Guide: A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 19 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05215639
Status: ACTIVE_NOT_RECRUITING
Condition: Acute Myeloid Leukemia
Phase: Not Specified

Where You Can Participate

This study is available at 19 locations across the country.

Top locations include:
  • • Klagenfurt am Wörthersee, Kaernten
  • • Sankt Poelten, Niederoesterreich
  • • Linz, Oberoesterreich
  • • And 16 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets - Join Clinical Trial NCTNCT05215639

How to Join This Clinical Trial - NCTNCT05215639

Learn how to participate in this Not Specified trial studying an investigational therapy for Acute Myeloid Leukemia. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute Myeloid Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute Myeloid Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05215639 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 19 locations. Find a study site near you:

Clinical Research Site

Klagenfurt am Wörthersee, Kaernten 9020 - Austria

Status: Contact for availability

Clinical Research Site

Sankt Poelten, Niederoesterreich 3100 - Austria

Status: Contact for availability

Clinical Research Site

Linz, Oberoesterreich 4010 - Austria

Status: Contact for availability

Clinical Research Site

Graz, Steiermark 8020 - Austria

Status: Contact for availability

Clinical Research Site

Leoben, Steiermark 8700 - Austria

Status: Contact for availability

Clinical Research Site

Vienna, Wien 1160 - Austria

Status: Contact for availability

Clinical Research Site

Wien, 1140 - Austria

Status: Contact for availability

Clinical Research Site

Aarau, Aargau 5001 - Switzerland

Status: Contact for availability

Clinical Research Site

Baden, Aargau 5404 - Switzerland

Status: Contact for availability

Clinical Research Site

Basel, Basel-Stadt 4031 - Switzerland

Status: Contact for availability

And 9 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Acute Myeloid Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships